Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MYPS
MYPS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MYPS News
Investment Risks and Opportunities in Small-Cap Stocks
Mar 17 2026
Yahoo Finance
PLAYSTUDIOS Reports Q4 Earnings Miss
Mar 17 2026
seekingalpha
PLAYSTUDIOS Reports 2025 Financial Results: Revenue Decline Amid Cost-Cutting Initiatives
Mar 16 2026
Newsfilter
PLAYSTUDIOS Scheduled to Announce Q3 2025 Results on November 3rd
Oct 24 2025
Newsfilter
Heather Dubrow, Poker Star Michael Mizrachi, and Other Special Guests to Feature at myVIP World Tournament of Slots 2025 at Atlantis Paradise Island, Backed by Jenny McCarthy's Promotion
Oct 21 2025
Newsfilter
PlayStudios (MYPS) To Report Earnings Tomorrow: Here Is What To Expect
Aug 03 2025
Yahoo Finance
PLAYSTUDIOS to Release Second Quarter 2025 Results August 4th
Jul 21 2025
Newsfilter
Insider Sale: General Counsel of $MYPS Sells 20,490 Shares
Jun 19 2025
NASDAQ.COM
Apple Faces Modest Earnings Hit After Court Ruling But Analyst Expects Match, Bumble, Spotify Set To Gain
Jun 05 2025
Benzinga
Apple's 27% Fee Cut Is Good News For Epic, App Developers, Google Remains Unaffected
May 05 2025
Benzinga
Roblox, Take-Two Level Up: But Can Gaming Stocks Survive A Macro Boss Fight?
Apr 22 2025
Benzinga
PLAYSTUDIOS to Release First Quarter 2025 Results May 5
Apr 21 2025
Newsfilter
PLAYSTUDIOS Announces Second Annual myVIP World Tournament of Slots at Atlantis Paradise Island Bahamas, Where Players from the Real and Digital Worlds Will Compete for a $1 Million Cash Prize
Apr 17 2025
Newsfilter
Insider Sale: Chief Financial Officer of $MYPS Sells 29,601 Shares
Apr 01 2025
NASDAQ.COM
JP Morgan's Top Video Game Stocks Of 2025
Mar 27 2025
Benzinga
Long-Term Shareholder Notice: Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf
Mar 12 2025
Globenewswire
Show More News
